Cytokinetics' IPO

Cytokinetics raised a round of funding on April 29, 2004. Investors include Public.

Cytokinetics is dedicated to the discovery, development and commercialization of a novel class of therapeutics resulting from its leadership position in the emerging field of cytoskeletal pharmacology…

Articles about Cytokinetics' IPO: